MAIA — MAIA BIOTECHNOLO

Ownership history in MARSHALL WACE, LLP  ·  2 quarters on record

This page tracks every 13F SEC filing in which MARSHALL WACE, LLP reported a position in MAIA BIOTECHNOLO (MAIA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 110,467 +94,302 +583.4% 0.00% $170K $1.54
2025 Q2 INITIATED 16,165 — — 0.00% $29K $1.80
% of Fund (quarterly)    MAIA price (monthly, adj. close)

Other funds also holding MAIA

As of 2025 Q4 — sorted by position size

Centric Wealth Management 3Y 7Y 0.24% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% StoneX Group Inc. 3Y 7Y 0.0% RITHOLTZ WEALTH MANAGEMENT 3Y 7Y 0.0% SRH ADVISORS, LLC 3Y 7Y 0.0% Cambridge Investment Research Advisors, Inc. 3Y 7Y 0.0% Creative Planning 3Y 7Y 0.0% WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 3Y 7Y 0.0% GEODE CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% VANGUARD GROUP INC 3Y 7Y 0.0%
← Back to MARSHALL WACE, LLP Holdings